PhRMA submission to USTR calls for urgent defense of American innovation abroad
The United States leads the world in medicine research, development and manufacturing, and international trade delivers those medicines to patients around the globe. But trade barriers imposed in many countries impede the ability of U.S. biopharmaceutical companies to export even more American-made medicines and employ even more scientists, researchers and factory workers.
Source: The Catalyst - Category: Pharmaceuticals Authors: Douglas Petersen Tags: Intellectual Property Trade TRIPS Waiver Source Type: news
More News: Pharmaceuticals | USA Health